while intraventricular injections of 6-hydroxydopamine enhance [ 3h ] dihydroalprenolol binding to beta-adrenergic receptors in the cerebral cortex and hippocampus , such binding is not augmented in the corpus striatum , brain stem , midbrain or thalamus-hypothalamus by this treatment .
C0006121
brain stem
C0025462
midbrain